Research News and Research

RSS

American, Canadian officials discuss global health developments at recent G8, G20 summits

The recent G8 summit in Canada's Muskoka region took an important step forward in improving maternal and child health in developing countries, Canadian and American officials said at a forum Wednesday in Washington, DC.

9 Jul 2010

Lawmakers, pundits offer mixed reaction to Berwick appointment

Politicians and pundits are reacting to President Barack Obama's recess appointment of Dr. Donald Berwick to run Medicare and Medicaid, with some saying such an appointment bypasses an important process while others praise the move.

9 Jul 2010

Experts to Medicare: Don't make the same pilot errors twice

The New York Times: Congress created the new $1 billion-a-year Center for Medicare and Medicaid Innovation to experiment with new — and possibly better or more efficient — ways to pay for and deliver health care as part of the overhaul law. But, the Center's efforts won't be Medicare's first attempts at innovation.

9 Jul 2010

KHN column -- High-risk pools: A rare opportunity for bipartisanship

In his latest Kaiser Health News column, Harold Pollack writes: "This month a key program created by the new health overhaul law, the Pre-Existing Condition Insurance Plan, becomes operational in many states. Over the next 40 months, this high-risk insurance pool will provide $5 billion to cover Americans who face the dual challenges of chronic illness and uninsurance.

8 Jul 2010

Onda celebrates 2000th hydrophone shipment

Onda Corporation, the global leader in ultrasound measurements, celebrated the 2000th hydrophone shipment. The hallmark unit, a polymer-based HNP hydrophone, shipped to St. Jude's Medical where it is used to test the acoustic properties of their medical transducers in production.

8 Jul 2010

CompuMed secures extended contracts with Oklahoma and Arizona's departments of corrections

CompuMed, Inc., a medical informatics and telemedicine services company, has secured extended contracts to provide its signature CardioGram™ electrocardiogram (ECG) remote interpretation systems and over-read services for the Oklahoma Department of Corrections (OKDOC) and Arizona Department of Corrections (ADC) at selected facilities throughout both states. The OKDOC rents 21 CardioGram systems, and the ADC owns 45 CardioGram systems.

8 Jul 2010

Infinity obtains global rights to Intellikine's portfolio of inhibitors of delta and gamma isoforms of PI3K

Infinity Pharmaceuticals, Inc., an innovative drug discovery and development company, and Intellikine, Inc., a leader in the development of small molecule drugs targeting the PI3K/mTOR pathway, today announced an agreement under which Infinity obtained global development and commercialization rights to Intellikine's portfolio of inhibitors of the delta and gamma isoforms of phosphoinositide-3-kinase.

8 Jul 2010

MDS Nordion to supply Mo-99 on weekly basis to Lantheus Medical Imaging

MDS Nordion, a leading provider of products and services to the global health science market, today announced it has signed a new contract with its primary customer, Lantheus Medical Imaging, Inc. for the supply of Molybdenum-99.

8 Jul 2010

Cannabis Science enters into long-term lease on 9,500 square foot facility in Denver, Colorado

Cannabis Science, Inc., a pioneering U.S. biotech company developing pharmaceutical cannabis products, is pleased to announce that it has entered into a long-term lease on a 9,500 square foot facility in Denver, Colorado, that will become its corporate offices, as well as serving as a research facility for developing, testing, and producing medical cannabis for patients in compliance with the new Colorado laws regulating medical marijuana in the state.

8 Jul 2010

Calithera Biosciences completes Series A financing totaling $40M

Calithera Biosciences, a company developing novel oncology therapeutics, today announced the completion of a Series A financing totaling $40 million. Morgenthaler Ventures led the financing with U.S. Venture Partners, Advanced Technology Ventures, Delphi Ventures and Mission Bay Capital also participating in the round. The capital will be used to support the company's pioneering efforts to develop activators of caspases, the proteases that promote apoptotic cell death, for the treatment of cancer and other proliferative diseases.

8 Jul 2010

WSBI, University of Colorado sign licensing agreement for TCISM targets

Western States Biopharmaceuticals, Inc., a privately-held biotechnology company focusing on the development of novel therapies to treat inflammatory disease, and the University of Colorado announced today that they have entered into a licensing agreement for approaches to inhibiting newly discovered T cell Cytokine Inducing Surface Molecules, or TCISM autoimmune disease drug discovery targets.

8 Jul 2010

Alimera Sciences submits MAA for Iluvien to MHRA

Alimera Sciences, Inc., a biopharmaceutical company that specializes in the research, development and commercialization of prescription ophthalmic pharmaceuticals has submitted a Marketing Authorization Application to the Medicines and Healthcare products Regulatory Agency in the United Kingdom for Iluvien (fluocinolone acetonide intravitreal insert).

8 Jul 2010

USF granted patent for cell transplantation procedure

The University of South Florida's Department of Neurosurgery and Brain Repair has been granted a patent for a cell transplantation procedure combining human umbilical cord blood cells and a sugar-alcohol compound called "mannitol" that may make a big difference in treating life-threatening neurodegenerative diseases such as Alzheimer's disease, Parkinson's disease, multiple sclerosis and stroke, among others.

8 Jul 2010

Jubilant Organosys Board approves amalgamation of SML & PMSL and demerger of APP business

Jubilant Organosys Limited, an integrated pharmaceutical industry player and the largest Custom Research and Manufacturing Services Company in India, today announced that the Board has approved the scheme of amalgamation and demerger. This is to enable focused growth and value realization across operating entities.

8 Jul 2010

Profil Institute for Clinical Research to support ADA's Step Out: Walk to Fight Diabetes

Profil Institute for Clinical Research, Inc., a company specializing in early phase clinical trials for diabetes and obesity, announced today that Dr. Marcus Hompesch, the company's President and CEO, will serve as San Diego's 2010 Corporate Chairman for Step Out: Walk to Fight Diabetes, the American Diabetes Association's largest fund-raising event.

8 Jul 2010

SIR and 41 international societies issue first global statement defining interventional radiology

The Society of Interventional Radiology, with the support of 41 international societies representing 10,000 interventional radiology doctors, has issued the first global statement defining interventional radiology-one designed to benefit medical treatment for individuals. The statement addresses the evolution, impact and future direction of this minimally invasive specialty, emphasizing the worldwide availability of this specialized medical care.

8 Jul 2010

Standard Process launches new ProSynbiotic product

By our first birthday, we've acquired over 400 bacterial passengers in our gastrointestinal tract. Our gut microbes, or "bugs," work to keep our complex and diverse gut ecosystem in balance. Unfortunately, the trials of daily life-stressful events, aging, diet, or immune challenges-can be hard on these bugs. Standard Process Inc. introduces a new product, ProSynbiotic, to help our body maintain a healthy, balanced gut ecosystem.

8 Jul 2010

First Edition: July 8, 2010

Today's headlines reflect the continued coverage of President Obama's recess appointment of Dr. Donald Berwick to head CMS as well as other developments related to Medicaid, the health insurance industry and state challenges to the health reform law.

8 Jul 2010

CF patients recover from exacerbations equally well when treated at home or in hospital: Researchers

Patients with cystic fibrosis recover from exacerbations equally well if they are treated at home or in a hospital, according to researchers from Johns Hopkins University. Furthermore, longer treatment with antibiotics does not appear to offer any additional benefit over shorter courses.

8 Jul 2010

NOSCAR completes first NOTES transoral and transvaginal gallbladder removal in U.S. human trial

The Natural Orifice Surgery Consortium for Assessment and Research- (NOSCAR-), a joint effort of the American Society for Gastrointestinal Endoscopy (ASGE) and the Society of American Gastrointestinal and Endoscopic Surgeons (SAGES), announces the completion of the first transoral and transvaginal cholecystectomies (gallbladder removal) using Natural Orifice Translumenal Endoscopic Surgery- (NOTES-) in a multicenter human trial in the United States.

From Evident Corporation - Life Sciences 8 Jul 2010

Research News and Research

American, Canadian officials discuss global health developments at recent G8, G20 summits

Lawmakers, pundits offer mixed reaction to Berwick appointment

Experts to Medicare: Don't make the same pilot errors twice

KHN column -- High-risk pools: A rare opportunity for bipartisanship

Onda celebrates 2000th hydrophone shipment

CompuMed secures extended contracts with Oklahoma and Arizona's departments of corrections

Infinity obtains global rights to Intellikine's portfolio of inhibitors of delta and gamma isoforms of PI3K

MDS Nordion to supply Mo-99 on weekly basis to Lantheus Medical Imaging

Cannabis Science enters into long-term lease on 9,500 square foot facility in Denver, Colorado

Calithera Biosciences completes Series A financing totaling $40M

WSBI, University of Colorado sign licensing agreement for TCISM targets

Alimera Sciences submits MAA for Iluvien to MHRA

USF granted patent for cell transplantation procedure

Jubilant Organosys Board approves amalgamation of SML & PMSL and demerger of APP business

Profil Institute for Clinical Research to support ADA's Step Out: Walk to Fight Diabetes

SIR and 41 international societies issue first global statement defining interventional radiology

Standard Process launches new ProSynbiotic product

First Edition: July 8, 2010

CF patients recover from exacerbations equally well when treated at home or in hospital: Researchers

NOSCAR completes first NOTES transoral and transvaginal gallbladder removal in U.S. human trial

Human iPSCs: A Full Guide to Advanced in Vitro Models and Applications eBook

Latest eBooks

A practical guide to lipid nanoparticle formulation and resizing

Editorial Focus eBook - Spatial and single-cell omics (1st edition)

Industry Focus eBook - Analytical Chemistry (3rd edition)

Industry Focus eBook - Microbiome (1st edition)

Improving healthcare sustainability through carbon data

Managing vibration in IVF laboratories

A New Approach to Preventing Bladder Cancer Recurrence